Cercle
AI NativeAdvancing women's healthcare by unlocking access to insights
Published Jul 14, 2026
No authoritative public market share estimates for Cercle were found in the reviewed sources.
| Starting Price | Not public (demo/enterprise) | Not public (appears enterprise) | Not public (varies) |
| Primary Fit | Fertility/women’s health providers seeking a graph-based data layer with analytics and LLM-based assistants (vendor-described) | IVF clinics seeking configurable AI decision support and EMR integration | IVF clinics and embryology workflows with AI components (public claims should be contractually verified) |
| Key Strength | Vendor positions product as specialized for women’s health data and analytics; early-stage funding and a patient/clinician application | Focus on IVF clinic workflows and EMR integration | Market presence in IVF-related AI; compliance claims should be validated during procurement |
| Key Weakness | Limited public independent reviews and case studies; public security attestations not clearly documented | Enterprise pricing opacity; customers should validate outcome impact | Buyers must verify clinical claims, regulatory posture, and real-world performance |
—